Huntingtin CAG repeat size variations outside the Huntington’s disease complex: associations with depression and anxiety phenotypes and basal ganglia structure

Abstract

ABSTRACT Huntington’s Disease (HD) is strongly associated with psychiatric symptoms, yet, associations between Huntingtin gene ( HTT ) CAG repeat size variations and psychiatric phenotypes outside the HD complex are still under-investigated. In this genetic case-control study we compared the distribution of HTT CAG repeat sizes in predefined ranges between patients with major depressive disorder (MDD) (n=2136) and anxiety disorders (ANX) (n=493), and healthy controls (CON) (n=1566). We used regression models to study interactions between the alleles and associations with fine-granular clinical phenotypes and basal ganglia structure. HD mutations in the range of incomplete penetrance (36-39 repeats) were not overrepresented in patients. In participants older than 48 years, 13-20 repeats on both HTT alleles were associated with a reduced ANX risk whereas a 13-20|21-26 combination was associated with an increased ANX risk. Post-hoc analyses confirmed a turning point around 21 repeats and trends in the same direction were detected for MDD. The joint patient|CON analysis of the full spectrum of allele combinations confirmed interaction effects and age-dependent allele|risk profiles. A short-by-long interaction effect and an age-dependent negative correlation of the short allele on the nucleus accumbens volume was detected, independently of the diagnostic group. In conclusion, we revealed that HTT CAG repeat sizes of both alleles in the non-HD range modulate the susceptibility for common psychiatric disorders and basal ganglia structure in an age-dependent way, displaying that normal variation of the functionally diverse wildtype huntingtin protein may already impact brain function.

Related Papers

• → A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington’s Disease(2018)332 cited
• → Molecular Research on Huntington’s Disease(2023)4 cited
• → NEOSTRIATAL HUNTINGTIN IMMUNOREACTIVITY CORRELATES WITH VULNERABILITY TO NEURODEGENERATION IN HUNTINGTONʼS DISEASE(1997)
• Assessments of potential interactions of huntingtin-associated-protein-1 in the R6/2 mouse model of Huntington's disease(2004)
• → Analysis of the huntingtin (HTT)-dependent transcriptome in brain from the R6/1 mouse model of Huntington’s disease(2019)